Seal Rock Therapeutics
Business Services · Washington, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
600 Stewart St Ste 400, Seattle, Washing...Phone Number
(206) 401-5086Website
www.sealrocktx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Seal Rock Therapeutics
Seal Rock Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class kinase inhibitors to address organ injury, inflammation, and fibrosis. Their drug discovery platform aims to create innovative treatments for liver and central nervous system diseases that currently have limited options. The company is backed by a management team with extensive experience in the biopharma sector and receives guidance from leading experts in the field. Seal Rock Therapeutics is dedicated to advancing medicine through breakthrough science.Explore more
Seal Rock Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Seal Rock Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Seal Rock Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Seal Rock Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Seal Rock Therapeutics
Check if Seal Rock Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Seal Rock Therapeutics has new funding data
Check out if Seal Rock Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Seal Rock Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Seal Rock Therapeutics launches new products
Recommended Actions
Reach out to Masked Content who joined Seal Rock Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to Seal Rock Therapeutics
Compare insights from companies similar to Seal Rock Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Seal Rock Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Seal Rock Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Seal Rock Therapeutics.
Seal Rock Therapeutics Tech Stack
A closer look at the technologies used by Seal Rock Therapeutics
See more technologies
Seal Rock Therapeutics News & Media
Seal Rock Therapeutics to Present Preclinical Efficacy Findings for SRT-015 in Cholestatic Liver Diseases at the European Association for Study of the Liver (EASL) Congress 2024
Abstract selected as TOP abstract for Congress Presentation SEATTLE, May 29, 2024 /PRNewswire/ -- Seal Rock Therapeutics, Inc., a clinical stage company developing first-in-class and best-in-class kinase inhibitors, today announced that it will present preclinical data on SRT-015 for...Seal Rock Therapeutics Announces Out-Licensing Agreement With GENFIT
SEATTLE, May 31, 2023 /PRNewswire/ — Seal Rock Therapeutics, Inc., a clinical stage company developing first-in-class and best-in-class kinase inhibitors,... Read More The post Seal Rock Therapeutics Announces Out-Licensing Agreement With GENFIT appeared first on citybiz.Seal Rock Therapeutics Announces Out-Licensing Agreement with GENFIT for Development of Injectable Formulation of SRT-015 for Acute-on-Chronic Liver Disease (ACLF)
Seal Rock eligible to receive payments up to €100 million, including regulatory, clinical, and commercial milestone payments, plus tiered royalties SEATTLE, May 31, 2023 /PRNewswire/ -- Seal Rock Therapeutics, Inc., a clinical stage company developing first-in-class and best-in-class...GENFIT Further Strengthens its ACLF Franchise with a Third Clinical-Stage Asset
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 31, 2023 - GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs, today announced it has licensed the exclusive worldwide rights of ASK1 Inhibitor SRT-015 (injectable formulation in acute liver disease2) from Seal Rock Therapeutics, a Seattle, Washington (USA) based clini
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Seal Rock Therapeutics
Sign Up For FreeTo access detailed company insights
Seal Rock Therapeutics is a clinical-stage biotechnology company focused on developing first-in-class kinase inhibitors to address organ injury, inflammation, and fibrosis. Their drug discovery platform aims to create innovative treatments for liver and central nervous system diseases that currently have limited options. The company is backed by a... Read More
